Search Results for "Grifols Biomat Company Profile"
Original Source: Grifols Biomat USA
Grifols Biomat USA is part of a large a network of plasma collection centers owned and operated by Grifols, a global healthcare company headquartered in Barcelona, Spain. Today, Grifols' plasma therapies are used to treat patients in more than 90 countries around the world. More information about Grifols Biomat USA and Grifols can be found at www.grifols.com.
Matching Channels
Matching News
Return to top 50 pharma list Summary Website: Grifols Headquarters: Barcelona, Spain Ticker Symbol: GRF:Continuous SEC Link: Grifols SEC filings Subsidiaries: Araclon Biotech PlasmaCare Talecris B...
[Grifols] acquires 60% of [Progenika] for €37mm
[Grifols SA] (hemotherapy, diagnostics, and hospital IV drugs) is acquiring a 60% stake in privately held diagnostics company [Progenika Biopharma SA] for €37mm ($48mm), half of which was paid in ca...
Annual Report for 2012 on Form 20-F filed with the SEC on April 5, 2013
BARCELONA, Spain, April 5, 2013 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ: GRFS), announced that it has filed its 2012 Annual Report on Form 20-F with the United States...
Grifols big pharma deals Aradigm in licensing and option agreement for Pulmaquin, Lipoquin and AERx
Grifols, a big pharma company, has entered pharma deals with Aradigm for licensing and options relating to Pulmaquin, Lipoquin and AERx. Grifols and Aradigm announced the signing of pharma deals...
Spain's Grifols says Q1 net profit up 19 pct y/y
MADRID, May 2 (Reuters) - Spanish pharmaceutical company Grifols said on Thursday net profit rose 19 percent in the first quarter of 2013 from a year earlier to 115.7 million euros ($152.6 million), b...
Grifols signs $90.7m respiratory deal with Aradigm
Grifols has signed a worldwide licensing agreement worth up to $90.7m to develop and commercialize Aradigm's formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin) for the treatment of severe...
Cangene to sell three U.S. plasma centres to Grifols
Biotech company Cangene Corp. (TSE:CNJ) Monday announced that it has agreed to sell three U.S. plasma centres to Biomat USA Inc., a wholly-owned subsidiary of Grifols (MCE:GRF), as part of its...
Grifols acquires 40% of Spanish biotech firm VCN Bioscience
Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the R&D...
Matching PubMed Articles
The relationship between the profile of the structures obtained by multiphoton polymerization and the optical parameters of nanofabrication systems has been studied theoretically for a multipulse sche...
The variant Creutfeldt-Jakob disease (vCJD) is a transmissible spongiform encephalopathy (TSE) associated with the ingestion of cattle derived products affected with bovine spongiform encephalopathy....
Characterization of the novel Listeria monocytogenes PCR serogrouping profile IVb-v1.
The World Health Organization Collaborating Centre for Listeria (WHOCCL) has developed in 2004 a multiplex PCR assay that separates the 4 major Listeria monocytogenes serovars (1/2a, 1/2b, 1/2c, and 4...
Strategies for improving the efficacy of bioengineered bone constructs: a perspective.
Bioengineered bone scaffolds are intended for use in large bone defects. Successful bone constructs should stimulate and support both the onset and the continuance of bone ingrowth. In an attempt to i...
Temperamental Profiles of Dysregulated Children.
It is crucial to characterize self-regulation in children. We compared the temperamental profiles of children with the Child Behavior Checklist (CBCL) Dysregulation Profile (CBCL-DP) to profiles assoc...
